Aktienanalyse wird geladen …
PH · NYSE · Specialty Industrial Machinery · USA
978,33 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 21,5 Mrd. | 3,65 Mrd. | 28,48 $ | 128,1 Mio. | 0,2 Mio · 0,1 % | 2,3 Mio · 1,8 % | 37,7 % | 17 % | 30,48 $ | 1,40 $ | 7,40 $ |
| 2025 | 19,85 Mrd. | 3,53 Mrd. | 27,12 $ | 130,2 Mio. | 0,2 Mio · 0,1 % | 0,2 Mio · 0,1 % | 36,9 % | 17,8 % | 25,66 $ | 1,22 $ | 6,69 $ |
| 2024 | 19,93 Mrd. | 2,84 Mrd. | 21,84 $ | 130,2 Mio. | 0,2 Mio · 0,1 % | — | 35,8 % | 14,3 % | 22,92 $ | 1,19 $ | 6,07 $ |
| 2023 | 19,07 Mrd. | 2,08 Mrd. | 16,04 $ | 129,9 Mio. | 0,1 Mio · 0,1 % | 0,6 Mio · 0,5 % | 33,7 % | 10,9 % | 20,01 $ | 1,10 $ | 5,47 $ |
| 2022 | 15,86 Mrd. | 1,32 Mrd. | 10,09 $ | 130,36 Mio. | 0,1 Mio · 0,1 % | 0,6 Mio · 0,5 % | 33,5 % | 8,3 % | 16,97 $ | 1,05 $ | 4,42 $ |
| 2021 | 14,35 Mrd. | 1,75 Mrd. | 13,35 $ | 130,83 Mio. | 0,1 Mio · 0,1 % | — | 33,1 % | 12,2 % | 18,08 $ | 0,93 $ | 3,67 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,76 Mrd. | 1,09 Mrd. | 8,52 $ | — | 19 % | 12,20 $ |
| Q1 2026 | 5,49 Mrd. | 904 Mio. | 7,06 $ | 128 Mio. | 16,5 % | 6,88 $ |
| Q4 2025 | 5,17 Mrd. | 845 Mio. | 6,60 $ | 128,1 Mio. | 16,3 % | 6,00 $ |
| Q3 2025 | 5,08 Mrd. | 808 Mio. | 6,29 $ | 128,4 Mio. | 15,9 % | 5,40 $ |
| Q2 2025 | 5,24 Mrd. | 923,04 Mio. | 7,15 $ | 129 Mio. | 17,6 % | 10,43 $ |
| Q1 2025 | 4,96 Mrd. | 961 Mio. | 7,38 $ | 130,3 Mio. | 19,4 % | 4,16 $ |
| Q4 2024 | 4,74 Mrd. | 948,54 Mio. | 7,25 $ | 130,8 Mio. | 20 % | 6,22 $ |
| Q3 2024 | 4,9 Mrd. | 698,42 Mio. | 5,34 $ | 130,7 Mio. | 14,2 % | 4,97 $ |
Axora Medical Expands Office-Based Gynecology Portfolio Through Partnership with Porter Instrument
BNP Paribas Adjusts PT on Parker-Hannifin to $1,270 From $1,220, Keeps Outperform Rating
Is Parker Hannifin (PH) Priced Right for Its Future Cash Flow?
Angle Seat Valve Market Forecasts Growth from $0.38B (2026) to $0.53B by 2032, Profiling Festo, Danfoss, Parker Hannifin, Alfa Laval & 21 Other Key Players
Parker-Hannifin Corporation is a global industrial and aerospace company specializing in motion and control technologies and systems. Parker-Hannifin designs and manufactures components and subsystems used to manage motion, flow, pressure, filtration, sealing, climate control, and process control across a wide range of applications. Its current business is organized around diversified industrial operations and aerospace systems, serving markets such as factory automation, transportation, energy, construction, food processing, HVAC, and commercial and military aviation. The company also supports customers with aftermarket and distribution capabilities through a broad network of products and service channels. Headquartered in Cleveland, Ohio, Parker-Hannifin plays a significant role in supplying precision-engineered solutions that improve efficiency, reliability, and performance in industrial and aerospace environments.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest PH und jede andere Aktie unbegrenzt.